{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:43:37Z","timestamp":1762299817445,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s42770-021-00552-w","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T02:09:51Z","timestamp":1625105391000},"page":"1719-1723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-5349","authenticated-orcid":false,"given":"J\u00e9ssica Louise","family":"Benelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanice Rodrigues","family":"Poester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Silveira","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Baracy","family":"Klafke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Orzechowski","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"552_CR1","unstructured":"World Health Organization (2018). Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children.https:\/\/www.who.int\/hiv\/pub\/guidelines\/cryptococcal-disease\/en\/Accessed 16 Apr 2021"},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/myc.12747","volume":"61","author":"F Bongomin","year":"2018","unstructured":"Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD (2018) A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses 61:290\u2013297. https:\/\/doi.org\/10.1111\/myc.12747","journal-title":"Mycoses"},{"key":"552_CR3","doi-asserted-by":"publisher","unstructured":"Robbins N, Wright GD, Cowen LE (2016). Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 4:https:\/\/doi.org\/10.1128\/microbiolspec.FUNK-0002-2016","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"key":"552_CR4","doi-asserted-by":"publisher","unstructured":"Benelli JL, Poester VR, Munhoz LS, et al (2021). Ebselen and diphenyl diselenide against fungal pathogens: a systematic review [published online ahead of print, 2021 Jan 9]. Med Mycol. https:\/\/doi.org\/10.1093\/mmy\/myaa115","DOI":"10.1093\/mmy\/myaa115"},{"key":"552_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa072","author":"AM Melo","year":"2020","unstructured":"Melo AM, Poester VR, Trapaga M et al (2020) Diphenyl diselenide and its interaction with antifungals against Aspergillus spp. Med Mycol. https:\/\/doi.org\/10.1093\/mmy\/myaa072","journal-title":"Med Mycol"},{"key":"552_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.101044","volume":"30","author":"LB da Silva","year":"2020","unstructured":"da Silva LB, Bock D, Klafke GB et al (2020) Cryptococcosis in HIV-AIDS patients from Southern Brazil: still a major problem. J Mycol Med 30:101044. https:\/\/doi.org\/10.1016\/j.mycmed.2020.101044","journal-title":"J Mycol Med"},{"key":"552_CR7","first-page":"25","volume-title":"Seleno-organic functional groups","author":"C Paulmier","year":"1986","unstructured":"Paulmier C (1986) Selenium reagents and intermediates in organic synthesis. Seleno-organic functional groups, 1st edn. Pergamon, Oxford, pp 25\u201357","edition":"1"},{"key":"552_CR8","unstructured":"Clinical and Laboratory Standards Institute (2017) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-fourth edition. CLSI document M27- A4.Wayne, PA. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27\/Accessed 16 Apr 2021"},{"key":"552_CR9","first-page":"432","volume-title":"Antibiotics in laboratory medicine","author":"GM Eliopoulos","year":"1991","unstructured":"Eliopoulos GM, Moellering RC (1991) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine, 3rd edn. Williams & Wilkins Co., Baltimore, MD, pp 432\u2013492","edition":"3"},{"key":"552_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. https:\/\/doi.org\/10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chemother"},{"key":"552_CR11","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1590\/S0103-50532010001100006","volume":"21","author":"CW Nogueira","year":"2010","unstructured":"Nogueira CW, Rocha JBT (2010) Diphenyl diselenide a janus-faced molecule. J Braz Chem Soc 21:2055\u20132071. https:\/\/doi.org\/10.1590\/S0103-50532010001100006","journal-title":"J Braz Chem Soc"},{"key":"552_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1742-7843.2007.00073.x","volume":"101","author":"AF De Bem","year":"2007","unstructured":"De Bem AF, Portella RDL, Farina M et al (2007) Low toxicity of diphenyl diselenide in rabbits: a long-term study. Basic Clin Pharmacol Toxicol 101:47\u201355. https:\/\/doi.org\/10.1111\/j.1742-7843.2007.00073.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"552_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12011-012-9464-z","volume":"150","author":"M Prigol","year":"2012","unstructured":"Prigol M, Br\u00fcning CA, Martini F, Nogueira CW (2012) Comparative excretion and tissue distribution of selenium in mice and rats following treatment with diphenyl diselenide. Biol Trace Elem Res 150:272\u2013277. https:\/\/doi.org\/10.1007\/s12011-012-9464-z","journal-title":"Biol Trace Elem Res"},{"key":"552_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/myc.12905","volume":"62","author":"L Rossato","year":"2019","unstructured":"Rossato L, Loreto ES, Venturini TP et al (2019) In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species. Mycoses 62:508\u2013512. https:\/\/doi.org\/10.1111\/myc.12905","journal-title":"Mycoses"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"e02108","DOI":"10.1128\/AAC.02108-16","volume":"61","author":"NT Grossman","year":"2017","unstructured":"Grossman NT, Casadevall A (2017) Physiological differences in Cryptococcus neoformans strains in vitro versus in vivo and their effects on antifungal susceptibility. Antimicrob Agents Chemother 61:e02108-e2116. https:\/\/doi.org\/10.1128\/AAC.02108-16","journal-title":"Antimicrob Agents Chemother"},{"key":"552_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208471","volume":"13","author":"CA Peng","year":"2018","unstructured":"Peng CA, Gaertner AAE, Henriquez SA, Fang D, Colon-Reyes RJ, Brumaghim JL et al (2018) Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro. PLoS ONE 13:e0208471. https:\/\/doi.org\/10.1371\/journal.pone.0208471","journal-title":"PLoS ONE"},{"issue":"1","key":"552_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12866-019-1606-4","volume":"19","author":"NH Dbouk","year":"2019","unstructured":"Dbouk NH, Covington MB, Nguyen K, Chandrasekaran S (2019) Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans. BMC Microbiol 19(1):243. https:\/\/doi.org\/10.1186\/s12866-019-1606-4","journal-title":"BMC Microbiol"},{"key":"552_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.chom.2013.02.002","volume":"13","author":"C Ding","year":"2013","unstructured":"Ding C, Festa RA, Chen YL et al (2013) Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence. Cell Host Microbe 13:265\u2013276. https:\/\/doi.org\/10.1016\/j.chom.2013.02.002","journal-title":"Cell Host Microbe"},{"key":"552_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1534\/genetics.113.150326","volume":"194","author":"IR Lee","year":"2013","unstructured":"Lee IR, Lui EY, Chow EW, Arras SD, Morrow CA, Fraser JA (2013) Reactive oxygen species homeostasis and virulence of the fungal pathogen Cryptococcus neoformans requires an intact proline catabolism pathway. Genetics 194:421\u2013433. https:\/\/doi.org\/10.1534\/genetics.113.150326","journal-title":"Genetics"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-021-00552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-021-00552-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-021-00552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T02:07:58Z","timestamp":1636510078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-021-00552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s42770-021-00552-w","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"type":"print","value":"1517-8382"},{"type":"electronic","value":"1678-4405"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors consented to the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}